TriSalus shareholders elect Wahlström and Matlin to board, ratify Grant Thornton

TriSalus Life Sciences, Inc.

Mats Wahlström and David J. Matlin elected to three-year terms with 20,002,109 and 20,005,151 votes for, respectively; 5,978,753 broker non-votes each.
Ratification of Grant Thornton as independent auditor for 2025: 26,445,528 for, 36,277 against, 994 abstain.
26,482,799 of 36,180,828 outstanding shares (73.2%) represented at the June 12, 2025 annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.